2023 - Research.com Medicine in Brazil Leader Award
2023 - Research.com Immunology in Brazil Leader Award
2022 - Research.com Medicine in Brazil Leader Award
2022 - Research.com Immunology in Brazil Leader Award
2012 - Fellow, The World Academy of Sciences
2005 - Fellow of John Simon Guggenheim Memorial Foundation
His primary areas of investigation include Immunology, Inflammation, Chemokine, Internal medicine and Endocrinology. His study in Immunology concentrates on Tumor necrosis factor alpha, CXCL1, Immune system, Cytokine and CXC chemokine receptors. His research integrates issues of Cell biology and Virology in his study of Immune system.
The Inflammation study combines topics in areas such as Apoptosis, Annexin A1, Receptor, Pharmacology and In vivo. His Chemokine research integrates issues from Trypanosoma cruzi, CCL5 and CD8. His study looks at the intersection of Endocrinology and topics like Rolipram with Enzyme inhibitor.
Mauro M. Teixeira mostly deals with Immunology, Inflammation, Internal medicine, Chemokine and Endocrinology. His study brings together the fields of Pharmacology and Immunology. His biological study spans a wide range of topics, including Reperfusion injury and Ischemia.
His studies deal with areas such as Receptor, Apoptosis and Arthritis as well as Inflammation. The various areas that Mauro M. Teixeira examines in his Internal medicine study include Gastroenterology, Chagas disease and Cardiology. His research investigates the connection between Chemokine and topics such as In vivo that intersect with problems in Chemotaxis.
The scientist’s investigation covers issues in Inflammation, Immunology, Internal medicine, Pharmacology and Endocrinology. His work carried out in the field of Inflammation brings together such families of science as Cytokine, Arthritis, Apoptosis, Lung and Efferocytosis. His research combines Disease and Immunology.
His Pharmacology research is multidisciplinary, relying on both Oxidative stress and Myeloperoxidase. Mauro M. Teixeira is studying Adipose tissue, which is a component of Endocrinology. His Chemokine study frequently draws parallels with other fields, such as Chemotaxis.
Mauro M. Teixeira mainly focuses on Immunology, Inflammation, Virology, Chemokine and Cell biology. The concepts of his Immunology study are interwoven with issues in Reperfusion injury and Microcephaly. His Inflammation research includes themes of Tissue homeostasis, Lung, Efferocytosis, Mediator and In vivo.
His study looks at the relationship between Virology and topics such as Immune system, which overlap with Pathogen, Lesion, Leishmania braziliensis, Cutaneous leishmaniasis and Dermis. His Chemokine research is multidisciplinary, incorporating elements of Liver injury, Chemotaxis and Pathology. The concepts of his Cell biology study are interwoven with issues in Natural killer T cell, CCR2, Interleukin 12 and Humanized mouse.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43
Kendle M. Maslowski;Angelica T. Vieira;Angelica T. Vieira;Aylwin Ng;Jan Kranich.
Experimental design and analysis and their reporting II: updated and simplified guidance for authors and peer reviewers
Michael J Curtis;Steve Alexander;Giuseppe Cirino;James R Docherty.
British Journal of Pharmacology (2018)
Metabolite-sensing receptors GPR43 and GPR109A facilitate dietary fibre-induced gut homeostasis through regulation of the inflammasome
Laurence Macia;Jian Tan;Angelica T. Vieira;Katie Leach.
Nature Communications (2015)
IL-33 Induces Antigen-Specific IL-5 + T Cells and Promotes Allergic-Induced Airway Inflammation Independent of IL-4
Mariola Kurowska-Stolarska;Pete Kewin;Grace Murphy;Remo C. Russo.
Journal of Immunology (2008)
Uric acid in chronic heart failure: a marker of chronic inflammation
F. Leyva;Stefan D. Anker;I. F. Godsland;M. Teixeira.
European Heart Journal (1998)
Cytokines and neurohormones relating to body composition alterations in the wasting syndrome of chronic heart failure.
S.D. Anker;P.P. Ponikowski;A.L. Clark;F. Leyva.
European Heart Journal (1999)
Resolution of Inflammation: What Controls Its Onset?
Michelle A. Sugimoto;Lirlândia P. Sousa;Vanessa Pinho;Mauro Perretti.
Frontiers in Immunology (2016)
Evolution and epidemic spread of SARS-CoV-2 in Brazil.
Darlan S. Candido;Darlan S. Candido;Ingra M. Claro;Jaqueline G. de Jesus;William M. Souza.
The CXCL8/IL-8 chemokine family and its receptors in inflammatory diseases
Remo C Russo;Cristiana C Garcia;Mauro M Teixeira;Flavio A Amaral.
Expert Review of Clinical Immunology (2014)
ARRIVE 2.0 and the British Journal of Pharmacology: Updated guidance for 2020.
Elliott Lilley;S. Clare Stanford;David E. Kendall;Stephen P.H. Alexander.
British Journal of Pharmacology (2020)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: